Company / Income Tax per Share
Terns Pharmaceuticals, Inc. Income Tax per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.00
FY2024
5-year range
$0.00 / $2.85
FY2020-FY2024
Trend
-2.5%
vs FY2023
Sector context
#96 of 194
Health Care
What the data says
At $0.00, Terns Pharmaceuticals, Inc.'s income tax per share ranks #99 of 194 in the Health Care sector. Income Tax per Share has declined for 4 consecutive years, from $2.85 in FY2020 to $0.00 in FY2024.
Based on SEC 10-K filings.
0.00 in FY2024 with a 3-year CAGR of -47.3%.
Improved from $0.01 to $0.00 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -47.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#99 of 194 in Health CareTop 51% of 194This company $0.00 Sector average $1.44
▼
-99.8% below sector average
Key checks
Key Insights
- Terns Pharmaceuticals, Inc.'s income tax per share has declined for 4 consecutive years.
- In FY2024, income tax per share decreased 2.5% year-over-year.
- Ranks #96 out of 194 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 7.86 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | -2.5% |
| FY2023 | $0.00 | -66.2% |
| FY2022 | $0.01 | -55.6% |
| FY2021 | $0.02 | -99.2% |
| FY2020 | $2.85 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026